165 related articles for article (PubMed ID: 31187845)
1. Delivery of drugs into brain tumors using multicomponent silica nanoparticles.
Turan O; Bielecki P; Perera V; Lorkowski M; Covarrubias G; Tong K; Yun A; Rahmy A; Ouyang T; Raghunathan S; Gopalakrishnan R; Griswold MA; Ghaghada KB; Peiris PM; Karathanasis E
Nanoscale; 2019 Jun; 11(24):11910-11921. PubMed ID: 31187845
[TBL] [Abstract][Full Text] [Related]
2. Treatment of glioblastoma using multicomponent silica nanoparticles.
Turan O; Bielecki PA; Perera V; Lorkowski M; Covarrubias G; Tong K; Yun A; Loutrianakis G; Raghunathan S; Park Y; Moon T; Cooley S; Dixit D; Griswold MA; Ghaghada KB; Peiris PM; Rich JN; Karathanasis E
Adv Ther (Weinh); 2019 Nov; 2(11):. PubMed ID: 32953978
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Invasive Brain Tumors Using a Chain-like Nanoparticle.
Peiris PM; Abramowski A; Mcginnity J; Doolittle E; Toy R; Gopalakrishnan R; Shah S; Bauer L; Ghaghada KB; Hoimes C; Brady-Kalnay SM; Basilion JP; Griswold MA; Karathanasis E
Cancer Res; 2015 Apr; 75(7):1356-65. PubMed ID: 25627979
[TBL] [Abstract][Full Text] [Related]
4. Tailoring Particle Size of Mesoporous Silica Nanosystem To Antagonize Glioblastoma and Overcome Blood-Brain Barrier.
Mo J; He L; Ma B; Chen T
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6811-25. PubMed ID: 26911360
[TBL] [Abstract][Full Text] [Related]
5. Crossing the barrier: treatment of brain tumors using nanochain particles.
Karathanasis E; Ghaghada KB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):678-95. PubMed ID: 26749497
[TBL] [Abstract][Full Text] [Related]
6. Spatial, Temporal, and Dose Control of Drug Delivery using Noninvasive Magnetic Stimulation.
Chen W; Cheng CA; Zink JI
ACS Nano; 2019 Feb; 13(2):1292-1308. PubMed ID: 30633500
[TBL] [Abstract][Full Text] [Related]
7. Preparation of silica nanoparticles loaded with nootropics and their in vivo permeation through blood-brain barrier.
Jampilek J; Zaruba K; Oravec M; Kunes M; Babula P; Ulbrich P; Brezaniova I; Opatrilova R; Triska J; Suchy P
Biomed Res Int; 2015; 2015():812673. PubMed ID: 26075264
[TBL] [Abstract][Full Text] [Related]
8. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
Juthani R; Madajewski B; Yoo B; Zhang L; Chen PM; Chen F; Turker MZ; Ma K; Overholtzer M; Longo VA; Carlin S; Aragon-Sanabria V; Huse J; Gonen M; Zanzonico P; Rudin CM; Wiesner U; Bradbury MS; Brennan CW
Clin Cancer Res; 2020 Jan; 26(1):147-158. PubMed ID: 31515460
[TBL] [Abstract][Full Text] [Related]
9. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of doxorubicin to mitochondria using mesoporous silica nanoparticle nanocarriers.
Qu Q; Ma X; Zhao Y
Nanoscale; 2015 Oct; 7(40):16677-86. PubMed ID: 26400067
[TBL] [Abstract][Full Text] [Related]
11. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
[TBL] [Abstract][Full Text] [Related]
12. Design of new protein drug delivery system (PDDS) with photoactive compounds as a potential application in the treatment of glioblastoma brain cancer.
de Melo MT; Piva HL; Tedesco AC
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110638. PubMed ID: 32204072
[TBL] [Abstract][Full Text] [Related]
13. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
14. Dual-Modified Novel Biomimetic Nanocarriers Improve Targeting and Therapeutic Efficacy in Glioma.
Fu S; Liang M; Wang Y; Cui L; Gao C; Chu X; Liu Q; Feng Y; Gong W; Yang M; Li Z; Yang C; Xie X; Yang Y; Gao C
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1841-1854. PubMed ID: 30582685
[TBL] [Abstract][Full Text] [Related]
15. Formation of oligonucleotide-gated silica shell-coated Fe₃O₄-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform.
Li WP; Liao PY; Su CH; Yeh CS
J Am Chem Soc; 2014 Jul; 136(28):10062-75. PubMed ID: 24953310
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery.
Tian Z; Xu Y; Zhu Y
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():452-459. PubMed ID: 27987731
[TBL] [Abstract][Full Text] [Related]
18. Nanoceria-triggered synergetic drug release based on CeO(2) -capped mesoporous silica host-guest interactions and switchable enzymatic activity and cellular effects of CeO(2).
Xu C; Lin Y; Wang J; Wu L; Wei W; Ren J; Qu X
Adv Healthc Mater; 2013 Dec; 2(12):1591-9. PubMed ID: 23630084
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in nanomedicine and survivin targeting in brain cancers.
Mazur J; Roy K; Kanwar JR
Nanomedicine (Lond); 2018 Jan; 13(1):105-137. PubMed ID: 29161215
[TBL] [Abstract][Full Text] [Related]
20. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography.
Chertok B; David AE; Yang VC
J Control Release; 2011 Nov; 155(3):393-9. PubMed ID: 21763736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
